News
October 16, 2007 – Celera developed a five-gene genetic risk score based on five variant genes that predict risk for coronary heart disease (CHD), according to a study published in the October 2007 edition of Genetics in Medicine, marking the potential development of personalized disease management in the cardiovascular arena.
October 15, 2007
Feature | Maureen Leahy-Patano
The clinical definition of intraoperative awareness — consciousness during general anesthesia — is a seemingly simple explanation for a complex, and controversial, phenomenon. Opinions surrounding how often intraoperative awareness, also described as anesthesia awareness, occurs, its implications for victims, as well as the best methods for prevention are varied.
October 15, 2007News
October 16, 2007 – Medtronic Inc. said in a statement that it has voluntarily suspended worldwide distribution of the Sprint Fidelis family of defibrillation leads because of the potential for lead fractures, and the company recommends that physicians do no perform new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949).
October 15, 2007Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
October 15, 2007 - Low-dose coronary CT angiogram (CCTA) could be better for testing asymptomatic patients for heart attack risk, according to researchers at Cedars-Sinai Medical Center, Los Angeles, CA.
October 14, 2007News
October 15, 2007 - Oncologists need to consider the affects on the cardiovascular system when treating early breast cancer, according to a review article in the Oct. 9 issue of the Journal of the American College of Cardiology.
October 14, 2007News
October 15, 2007 - Siemens Medical Solutions Molecular Imaging Division will introduce the new Symbia E series single ...
October 14, 2007Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Technology
Siemens Medical Solutions Molecular Imaging Division's Symbia E series single photon emission computed tomography (SPECT ...
October 14, 2007News
October 10, 2007 - Medtronic Inc. announced that an FDA advisory committee has recommended the Endeavor drug-eluting ...
October 10, 2007News
October 11, 2007 - GE Healthcare, a unit of General Electric Company, today announced that it has completed the ...
October 10, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
October 10, 2007 - A new technique for capturing images of chest veins eases diagnosis of venous diseases, according to ...
October 09, 2007
Technology
Carestream Health’s KODAK DIRECTVIEW CR Mammography feature adds mammography applications to its CR platforms along with ...
October 09, 2007News
October 10, 2007 - Premier Purchasing Partners, LP, announced new agreements have been awarded for diagnostic imaging ...
October 09, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
October 9, 2007 - Medtronic Inc. will provide a synopsis of clinical data on the Endeavor Drug Eluting Coronary Stent to ...
October 08, 2007Technology
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
October 08, 2007News
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
October 08, 2007